Your Primer to Healthcare Mergers and Acquisitions

Where's My Cash? Dispelling A Common Misconception About PE-Backed Acquisitions

Mar 28, 2019

by Dave Turgeon

by Dave Turgeon, Managing Director

Volume 6 Issue 6, March 28, 2019

Physician practice owners are often surprised to learn how private equity (PE)-backed companies structure their acquisitions and the relatively small amount of cash paid at closing. It's significantly less than owners (sellers) expected.

Below is a simple breakdown of how the proceeds from a typical PE acquisition works. The selling price is generally paid in three parts. Understanding the timing of these payouts may influence when owners choose to sell their practices.

Cash at Closing: 40%

Less than half of the sale price may be paid upon closing. Practice owners should keep in mind that they will pay their transaction costs from this amount. These costs will include the fees for services provided by an accountant, lawyer, and advisor and may also include taxes.

Deferred Payments: 40%

Most states have strict laws prohibiting non-compete contracts for physicians. The justification is that prohibiting the practice of medicine in any form is considered to be against the public's interest. The challenge for buyers is that they do not want to acquire a practice only to see its physicians walk away a short time after the sale and become competition.

PE-backed companies work around this by paying some of the acquisition price over time, i.e., deferring a portion of the payment. This amount — typically 40% of the acquisition price — is usually spread over three or four years. The payment is also predicated on the practice continuing to generate the revenue and cash flow (EBITDA) upon which the sales price was determined. This approach serves as motivation for practice owners to keep their team in place to sustain the practice's financial performance.

During the deferred payments period, physician-owners continue to be paid on a formula based upon collections from services provided (e.g., 50% less certain expenses). They do not, however, share in the profits of the business post sale.

Note: Keep in mind that, in general, such deferred payments are treated as capital gains for tax purposes.

Rollover Equity: 20%

The concept here is that physician-owners are swapping stock in their company for an equal value of stock in the company acquiring their practice. The physicians are not paid cash for this portion of the sale. The stock can usually be monetized upon the sale of the buyer's company.

The incentive for buyers is they want their new physician partners to be aligned with the parent company's interests. By accepting stock in a buyer's company, physicians become financially invested in that company's success.

A seller may find this offering very attractive for a couple reasons. First, accepting stock rather than cash defers any taxes on the gain from the transaction. Second, the buyer is likely to sell the company at a significant gain. As a shareholder, the seller will participate in that gain. It's not unreasonable to expect a gain of 300-400% over a period of just 2-4 years.

To better ensure such an optimal outcome, it is imperative to work with the right buyer and PE group. An advisor can provide the best direction on this matter.

Key Takeaway

I often get calls from business owners considering retirement who believe it may take just 3-6 months to sell their business. They're surprised to learn that buyers expect owners to remain with the business for the time periods discussed above. This misconception — and others as well — can create significant challenges that have the potential to derail an owner's plans and expectations for selling a business. Such a scenario is avoidable.

Surrounding oneself with experienced people is critical for a successful sale. If you envision possibly selling your business within the next few years, begin researching and identifying the team members who will support you now. They will help dispel any misconceptions you may have about the sale process and better ensure that the exit you envision is the one you actually experience.

Dave Turgeon

Dave Turgeon CM&AA

Managing Director

Dave's professional work history includes:

  • Vice President of Mergers & Acquisitions at Civitas Solutions and oversaw the completion of over 80 acquisitions and 10 divestitures. Civitas went public in 2014.
  • Managed the Mergers & Acquisitions Department at ReMed Recover Care, LLC. The company sold to Baird Capital in 2018.
  • Vice President of Mergers & Acquisitions at United Site Services (USS) during its period of explosive growth. The company sold to DLJ Merchant Banking in 2007.
  • Founder and CEO of MembersFirst during the “internet phase” of the late 1990’s and early 2000’s.
  • Senior Vice President at Browning-Ferris Industries. Responsibilities included Finance, Operations and Acquisitions. The company acquired hundreds of companies and grew revenues to over $12B.

He first became involved in the Behavioral Health space because of the disability of a family member.  The mission of these companies is both noble and personal to Dave. He helps business owners with the sale of their business, which means getting them the best value and terms. For him, it means thanking them for making the lives of others better.

We can help you with more information on this and related topics. Contact us today!

Committed to Constant Improvement?

Subscribe to our bi-weekly newsletter – SalientValue

No Spam Ever. We Promise.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram